Anacor Pharmaceuticals (ANAC)
Create an AlertAnacor Pharmaceuticals PE Ratio TTM
Anacor Pharmaceuticals Historical PE Ratio TTM Data
Pro Data ExportThere is no data for the selected date range.
About Price to Earnings Ratio
The price to earnings ratio (PE Ratio) is the measure of the share price relative to the annual net income earned by the firm per share. PE ratio shows current investor demand for a company share. A high PE ratio generally indicates increased demand because investors anticipate earnings growth in the future. The PE ratio has units of years, which can be interpreted as the number of years of earnings to pay back purchase price.
PE ratio is often referred to as the "multiple" because it demonstrates how much an investor is willing to pay for one dollar of earnings. PE Ratios are sometimes calculated using estimations of next year's earnings per share in the denominator. When this happens, it is usually noted.
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More
ANAC PE Ratio TTM Benchmarks
| Companies | |
|---|---|
| QLT | 8.526 |
| Valeant Pharmaceuticals International | |
| Santarus | 43.28 |
